BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
Ezetimib, toote foto
Medication

Ezetimib

Medication

  • Saadetakse Saksamaalt

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

Lühidalt

Ezetimib arvudes

Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.

Täielik leksikoni artikkel

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~22 hours

Half-life ~22 hours
After 44 hours: 25 %
Hour 2250 %Hour 24, next dose47 %Hour 4425 %Hour 6612.5 %Hour 1103.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about22hours

Class
Cholesterol absorption inhibitorNPC1L1 blocker
Use
Oral10mg once daily
Sizes
10 mg1 size in the shop

Teadmised

Kõik teemal Ezetimib

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

Is ezetimibe approved?

Yes. ChEMBL lists ezetimibe with phase 4 as the highest phase and first approval in 2002, as a drug for raised cholesterol. ClinicalTrials.gov lists 491 trials with ezetimibe, as of 26 October 2026.

How does ezetimibe work?

It inhibits NPC1L1, a transporter at the brush border of small intestine cells that takes up cholesterol. Mice without NPC1L1 absorbed much less cholesterol and ezetimibe no longer worked in them. A year later a binding study showed that ezetimibe binds directly to NPC1L1.

How much does ezetimibe lower LDL?

Given alone, by 18.6 percent more than placebo on average, according to the meta-analysis of eight trials over 12 weeks. Total cholesterol fell by 13.5 percent, triglycerides by 8.1 percent and HDL rose by 3.0 percent.

What did IMPROVE-IT show?

18,144 people after an acute coronary syndrome received a statin plus ezetimibe or a statin plus placebo. LDL during the trial was 1.4 instead of 1.8 mmol/l. At 7 years 32.7 instead of 34.7 percent had a cardiovascular event. The difference is small, but it was the first large proof of added benefit from a non-statin.

How long does ezetimibe stay in the body?

The half-life is about 22 hours. Ezetimibe is converted in the gut and liver into an active glucuronide that returns to the gut via the bile. About 78 percent is excreted in the faeces.

Which side effects and interactions are known?

In SHARP and IMPROVE-IT muscle, liver and gallbladder events and cancer were about as common as in the comparison group. Bile acid sequestrants such as colestyramine clearly reduce ezetimibe uptake, ciclosporin raises its level. Fibrates raise it as well, according to the review probably of minor clinical relevance.

Seotud

Seotud tooted